Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Semmler

Showing results (11-20 of 196) with videos related to

Pageof 20
Sort By:
Clinical and Molecular Hepatology|November 23, 2022
Non-invasive tests-based risk stratification: Baveno VII and beyondGeorg Semmler, Mathias Jachs, Mattias Mandorfer
Hepatology (Baltimore, Md.)|June 9, 2025
Roadmap for a generally accepted model to predict first hepatic decompensation in compensated advanced chronic liver diseaseMattias Mandorfer, Mathias Jachs, Georg Semmler
Journal of Hepatology|August 11, 2023
What's in a name? New nomenclature for steatotic liver disease - to be or not to be?Georg Semmler, Bernhard Wernly, Christian Datz
Journal of Hepatology|July 22, 2022
Reply to: "HCC prediction post SVR: many tools yet limited generalizability!": De novo HCC risk stratification after HCV cure: All roads lead to Rome?Georg Semmler, Elias Laurin Meyer, Mattias Mandorfer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2022
Nomenclature Dilemma of MAFLD Across the Globe: Our Prism to Understand Metabolic Dysfunction and Cardiovascular Risk in MAFLDGeorg Semmler, Sarah Wernly, Bernhard Wernly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Letter to Niezen and colleaguesGeorg Semmler, Matthias Egger, Elisa Hefner, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Letter to the Editor: Dynamics in liver stiffness to assess response in MASLD patients treated with resmetirom-One piece of the puzzle?Georg Semmler, Maja Thiele, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2026
Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic RecompensationBenedikt Silvester Hofer, Jan Embacher, Georg Semmler, et al.
JHEP Reports : Innovation in Hepatology|March 8, 2026
Reply to: "Gene-environment "amplification" of liver stiffness requires more clinically meaningful analytic approaches"Sophie Gensluckner, Helle Lindholm Schnefeld, Maja Thiele, et al.
Pageof 20

Showing results (11-20 of 196) with videos related to

Sort By:
Pageof 20
Clinical and Molecular Hepatology|November 23, 2022
Non-invasive tests-based risk stratification: Baveno VII and beyondGeorg Semmler, Mathias Jachs, Mattias Mandorfer
Hepatology (Baltimore, Md.)|June 9, 2025
Roadmap for a generally accepted model to predict first hepatic decompensation in compensated advanced chronic liver diseaseMattias Mandorfer, Mathias Jachs, Georg Semmler
Journal of Hepatology|August 11, 2023
What's in a name? New nomenclature for steatotic liver disease - to be or not to be?Georg Semmler, Bernhard Wernly, Christian Datz
Journal of Hepatology|July 22, 2022
Reply to: "HCC prediction post SVR: many tools yet limited generalizability!": De novo HCC risk stratification after HCV cure: All roads lead to Rome?Georg Semmler, Elias Laurin Meyer, Mattias Mandorfer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2022
Nomenclature Dilemma of MAFLD Across the Globe: Our Prism to Understand Metabolic Dysfunction and Cardiovascular Risk in MAFLDGeorg Semmler, Sarah Wernly, Bernhard Wernly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2021
Letter to Niezen and colleaguesGeorg Semmler, Matthias Egger, Elisa Hefner, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Letter to the Editor: Dynamics in liver stiffness to assess response in MASLD patients treated with resmetirom-One piece of the puzzle?Georg Semmler, Maja Thiele, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2026
Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic RecompensationBenedikt Silvester Hofer, Jan Embacher, Georg Semmler, et al.
JHEP Reports : Innovation in Hepatology|March 8, 2026
Reply to: "Gene-environment "amplification" of liver stiffness requires more clinically meaningful analytic approaches"Sophie Gensluckner, Helle Lindholm Schnefeld, Maja Thiele, et al.
Pageof 20